Cooper Companies (The) (COO) fundamentals: P/E, valuation, undervalued?
Cooper Companies (The) · Health Care · ref. ETF XLV · price $54.59
In short — Cooper Companies (The) trades at 19.1× earnings (P/E), 11.6× forward, with a net margin of 13.5 % and revenue growth of +1 %. Read: Cheap for the growth (P/E 12 for ~357% growth (PEG 0.0)).
Is Cooper Companies (The) stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$54.59-23.3% over range
Oct 14, 25low $53.27 · high $84.32Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
31% recommend buying · 13 analysts
Valuation : Cheap for the growth — P/E 12 for ~357% growth (PEG 0.0)
Valuation
19.1
P/E (price/earnings)
11.6
Forward P/E
0.05
PEG
1.2
Price/book (P/B)
$10.4B
Market cap
2.86
EPS
Profitability & growth
13.5 %
Net margin
+1 %
Revenue growth
+357 %
Earnings growth
$2.8B
Total debt
Cooper Companies (The) income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $3.3B | $386M | 11.7 % |
| 2023 | $3.6B | $294M | 8.2 % |
| 2024 | $3.9B | $392M | 10.1 % |
| 2025 | $4.1B | $375M | 9.2 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Cooper Companies (The)'s P/E and is the stock undervalued? What's a good P/E?
Cooper Companies (The)'s P/E is 19.1 (forward 11.6). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Cheap for the growth".
Is Cooper Companies (The) profitable?
Cooper Companies (The) has a net margin of 13.5 % (EPS 2.86). The company is profitable.
Is COO stock expensive?
Our read: "Cheap for the growth" — P/E 12 for ~357% growth (PEG 0.0). Cross-check with growth and sector.
💬 A question about Cooper Companies (The)? The JPI assistant answers using our backtest data.
Keep exploring Cooper Companies (The)